| Literature DB >> 28492787 |
Mehmet Kalender1, Ahmet Nihat Baysal1, Okay Guven Karaca2, Kamil Boyacioglu3, Nihan Kayalar3.
Abstract
OBJECTIVE: : Risk assessment for operative mortality is mandatory for all cardiac operations. For some operation types such as aortic valve repair, EuroSCORE II overestimates the mortality rate and a new scoring system (German AV score) has been developed for a more accurate assessment of operative risk. In this study, we aimed to validate German Aortic Valve Score in our clinic in patients undergoing isolated aortic valve replacement.Entities:
Mesh:
Year: 2017 PMID: 28492787 PMCID: PMC5409257 DOI: 10.21470/1678-9741-2016-0029
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Patients' characteristics. German Aortic Valve Score.
| n | % | Mortality | ||
|---|---|---|---|---|
| Age group (years) | <66 | 20 | 57.14 | 5 |
| 66-70 | 5 | 14.29 | 0 | |
| 71-75 | 7 | 20 | 1 | |
| 76-80 | 3 | 8.571 | 0 | |
| Sex | Male | 21 | 60 | 5 |
| Female | 14 | 40 | 1 | |
| BMI | 22-35 | 25 | 71.43 | 4 |
| <22 | 8 | 22.86 | 2 | |
| >35 | 2 | 5.71 | 0 | |
| Heart failure: NYHA IV | NYHA<IV | 34 | 97.14 | 6 |
| NYHA=IV | 1 | 2.85 | 0 | |
| Myocardial infarction < 3 weeks | 0 | 0 | 0 | |
| Critical preoperative status | 0 | 0 | 0 | |
| Pulmonary hypertension | 13 | 37.14 | 3 | |
| No sinus rhythm | 4 | 11.43 | 1 | |
| LVEF (%) | <30 | 1 | 2.857 | 0 |
| 30-50 | 10 | 28.57 | 1 | |
| >50 | 24 | 68.57 | 5 | |
| Endocarditis | 1 | 2.85 | 0 | |
| Reoperation | 1 | 2.85 | 0 | |
| Peripheral arterial disease | 0 | 0 | 0 | |
| Chronic obstructive pulmonary disease | 5 | 14.29 | 1 | |
| Chronic renal insufficiency | 2 | 5.714 | 1 | |
| Emergency | 2 | 5.714 | 0 | |
| Observed mortality | 6 | 17.14 | 6 | |
BMI = body mass index; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association
Patients' characteristics. EuroSCORE II.
| n | % | Mortality | |
|---|---|---|---|
| Patient related factors | |||
| Age (years) | 61.14±13.25 | 6 | |
| Female | 14 | 40 | 1 |
| Peripheral arteriopathy | 0 | 0 | 0 |
| Chronic obstructive pulmonary disease | 5 | 14.3 | 1 |
| Diabetes on insulin | 3 | 8.6 | 0 |
| Poor mobility | 0 | 0 | 0 |
| Renal impairment | |||
| Dialysis | 2 | 5.71 | 1 |
| CC<50 | 5 | 14.28 | 0 |
| 85<CC>50 | 20 | 57.14 | 2 |
| CC>85 | 8 | 22.85 | 2 |
| Cardiac related factors | |||
| Active endocarditis | 1 | 2.9 | 0 |
| Recent AMI | 0 | 0 | 0 |
| NYHA class | |||
| II | 31 | 88.4 | 4 |
| III | 3 | 8.7 | 2 |
| IV | 1 | 2.9 | 0 |
| CCS4 | 0 | 0 | |
| LVEF (%) | |||
| >50 | 24 | 68.57 | 5 |
| 31-50 | 10 | 28.57 | 1 |
| 21-30 | 1 | 2.85 | 0 |
| <20 | 0 | 0 | 0 |
| Pulmonary artery pressure | |||
| 31-55 mmHg | 3 | 8.7 | 0 |
| >55 mmHg | 1 | 2.9 | 1 |
| Procedure | |||
| Critical Condition | 0 | 0 | 0 |
| Re-operation | 1 | 2.9 | 1 |
| Thoracic aorta | 0 | 0 | 0 |
| Emergency | |||
| Urgent | 0 | 0 | 0 |
| Emergent | 2 | 5.7 | 0 |
| Salvage | 0 | 0 | 0 |
| Weight of procedure | |||
| Single non-CABG | 35 | 100 | 6 |
AMI = acute myocardial infarction; CABG = coronary artery bypass grafting; CCS = Canadian Cardiovascular Society; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association
Fig. 1The receiver operating characteristic (ROC) curve of German aortic valve score.
Contingency table for Hosmer–Lemeshow test (German Aortic Valve Score).
| Observed mortality = 0 | Observed mortality = 1 | Total | |||
|---|---|---|---|---|---|
| Observed | Expected | Observed | Expected | Observed | |
| 1 | 4 | 3.967 | 0 | 33 | 4 |
| 2 | 4 | 3.778 | 0 | 222 | 4 |
| 3 | 4 | 4.423 | 1 | 577 | 5 |
| 4 | 4 | 4.916 | 2 | 1.084 | 6 |
| 5 | 5 | 3.939 | 0 | 1.061 | 5 |
| 6 | 4 | 4.514 | 2 | 1.486 | 6 |
| 7 | 4 | 3.462 | 1 | 1.538 | 5 |
Fig. 2The receiver operating characteristic (ROC) curve of EuroSCORE II.
Contingency table for Hosmer–Lemeshow test (EuroSCORE II).
| Observed mortality = 0 | Observed mortality = 1 | Total | |||
|---|---|---|---|---|---|
| Observed | Expected | Observed | Expected | Observed | |
| 1 | 4 | 3.972 | 0 | 0.028 | 4 |
| 2 | 4 | 3.763 | 0 | 0.237 | 4 |
| 3 | 4 | 3.633 | 0 | 0.367 | 4 |
| 4 | 4 | 3.443 | 0 | 0.557 | 4 |
| 5 | 1 | 3.258 | 3 | 0.742 | 4 |
| 6 | 3 | 3.145 | 1 | 0.855 | 4 |
| 7 | 3 | 3.003 | 1 | 0.997 | 4 |
| 8 | 4 | 3.458 | 1 | 1.542 | 5 |
| 9 | 2 | 1.326 | 0 | 0.674 | 2 |
| Abbreviations, acronyms & symbols | |
|---|---|
| BMI | = Body mass index |
| EuroSCORE | = European System for Cardiac Operation Risk |
| Evaluation | |
| ROC | = Receiver operating characteristic |
| TAVI | = Transcatheter aortic valve implantation |
| Authors' roles & responsibilities | |
|---|---|
| MK | Conception and study design; realization of operations;
analysis and/or data interpretation; statistical |
| ANB | Conception and study design; realization of operations;
|
| OGK | Conception and study design; realization of operations;
|
| KB | Conception and study design; realization of operations;
|
| NK | Conception and study design; realization of operations;
|